| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE | 10 |
| 1 | OMEPRAZOLE MAGNESIUM | 10 |
| 2 | ENOXAPARIN SODIUM | 5 |
| 3 | SIMVASTATIN | 5 |
| 4 | ALPRAZOLAM | 4 |
| 5 | BRIMONIDINE | 4 |
| 6 | BRIMONIDINE TARTRATE | 4 |
| 7 | DARUNAVIR | 4 |
| 8 | DOLUTEGRAVIR SODIUM | 4 |
| 9 | FLUOXETINE HYDROCHLORIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALFUZOSIN HYDROCHLORIDE | 2 | 0.0008 |
| 1 | FONDAPARINUX SODIUM | 4 | 0.0005 |
| 2 | DOLUTEGRAVIR SODIUM | 4 | 0.0004 |
| 3 | DARUNAVIR | 4 | 0.0003 |
| 4 | BRIMONIDINE TARTRATE | 4 | 0.0002 |
| 5 | INSULIN GLARGINE-YFGN | 4 | 0.0002 |
| 6 | BENDAMUSTINE HCL | 2 | 0.0001 |
| 7 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 8 | INDAPAMIDE | 2 | 0.0001 |
| 9 | DABRAFENIB | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 10 |
| 1 | Insulin Analog [EPC] | 8 |
| 2 | Corticosteroid [EPC] | 5 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 5 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 4 |
| 5 | Benzodiazepine [EPC] | 4 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 4 |
| 7 | GLP-1 Receptor Agonist [EPC] | 4 |
| 8 | Protease Inhibitor [EPC] | 4 |
| 9 | Thiazide-like Diuretic [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 4 | 0.0001 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 4 | 0.0001 |
| 2 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 3 | Thiazide-like Diuretic [EPC] | 2 | 0.0000 |
| 4 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Alkaloid [EPC] | 1 | 0.0000 |
| 6 | Insulin Analog [EPC] | 8 | 0.0000 |
| 7 | Proton Pump Inhibitor [EPC] | 10 | 0.0000 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 5 | 0.0000 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 4 | 0.0000 |